Concepedia

Generic Modified-release Product Development

Generic Modified-Release Product Development is a pharmaceutical formulation strategy that involves the systematic design and optimization of bioequivalent, non-innovator modified-release dosage forms to achieve therapeutic interchangeability through controlled pharmacokinetic profiles.

6

Publications

157

Citations

42

Authors

10

Institutions

Publications per year

2017–2026

1

Parents

Publications

6

Pharmaceutical Equivalence by Design for Generic Drugs: Modified-Release Products

Andre Raw, Robert Lionberger, Lawrence X. Yu · Pharmaceutical Research · 2011 · 48 citations

, , +16

Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.

A Marzo, L P Balant · PubMed · 1995 · 43 citations

, , +17

Comparison of two marketed nifedipine modified-release formulations: An exploratory clinical food interaction study

Meinolf Wonnemann, Barbara Schug, Maria Anschütz et al. · Clinical Therapeutics · 2008 · 26 citations

, , +14

IVIVC: Methods and Applications in Modified-Release Product Development

Harald Rettig, Jana Mysicka · Dissolution Technologies · 2008 · 14 citations · Full text

, , +11

Development of a Factory Process for Omecamtiv Mecarbil, a Novel Cardiac Myosin Activator

Seb Caille, Alan M. Allgeier, Charles Bernard et al. · Organic Process Research & Development · 2019 · 14 citations

, , +9

1–5 of 6

Authors

42

  1. TL
    Tiffany L. Correll

    Amgen (United States), United States

    1 publications · 14 citations

    1

    h-index

  2. PC
    Philipp C. Roosen

    University of California, Irvine, United States

    1 publications · 14 citations

    1

    h-index

  3. JM
    Jana Mysicka

    Mundipharma (United Kingdom), United Kingdom

    1 publications · 14 citations

    1

    h-index

  4. HR
    Harald Rettig

    Novartis (Switzerland), Switzerland

    1 publications · 14 citations

    1

    h-index

  5. AM
    A Marzo

    Sigma Tau (Italy), Italy

    1 publications · 43 citations

    1

    h-index

1–5 of 42

Institutions

10

  1. Machine Science

    Cambridge, United States

    1 h-index

    1 publications

    43 citations

  2. Bayer (Germany)

    Leverkusen, Germany

    1 h-index

    1 publications

    26 citations

  3. United States Food and Drug Administration

    Silver Spring, United States

    1 h-index

    3 publications

    144 citations

  4. Auburn University

    Auburn, United States

    1 h-index

    1 publications

    12 citations

  5. University of Massachusetts Amherst

    Amherst Center, United States

    1 h-index

    1 publications

    12 citations

  6. Cytokinetics (United States)

    South San Francisco, United States

    1 h-index

    2 publications

    28 citations

  7. Massachusetts College of Pharmacy and Health Sciences

    Boston, United States

    1 h-index

    1 publications

    12 citations

  8. Amgen (United States)

    Thousand Oaks, United States

    1 h-index

    24 publications

    336 citations

1–8 of 10

Venues

  1. Clinical Therapeutics

    1 publications · 26 citations

    1

    h-index

  2. PubMed

    Repository · 1 publications · 43 citations

    1

    h-index

  3. Pharmaceutical Research

    1 publications · 48 citations

    1

    h-index

  4. Clinical Drug Investigation

    1 publications · 12 citations

    1

    h-index

  5. Dissolution Technologies

    1 publications · 14 citations

    1

    h-index

1–5